Kindstar Globalgene Eyes Biotech Acquisitions

Kindstar Globalgene Technology, Inc. (HK:9960) has released an update.

Kindstar Globalgene Technology, Inc. has announced its intention to acquire 100% equity interest in two biotech companies, Guangzhou Kangcheng Weiye Biotechnology Co., Ltd. and AnchorDx Inc. These proposed acquisitions are currently in negotiation stages and have not yet resulted in any legally binding agreements. Shareholders and potential investors have been cautioned to exercise care when dealing in the company’s securities.

For further insights into HK:9960 stock, check out TipRanks’ Stock Analysis page.